RAYMOND JAMES & ASSOCIATES - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$30,996
+1.8%
31,0000.0%0.00%
Q4 2022$30,458
+1.5%
31,0000.0%0.00%
Q3 2022$30,0000.0%31,0000.0%0.00%
Q2 2022$30,0000.0%31,0000.0%0.00%
Q1 2022$30,000
-3.2%
31,0000.0%0.00%
Q4 2021$31,000
+3.3%
31,0000.0%0.00%
Q3 2021$30,00031,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders